G7i / 17B15: List the properties of an ideal inotope. How does adrenaline compare to these ideal properties

17B15: Exam Report

List the properties of an ideal inotrope (50% of marks). How does adrenaline compare to these ideal properties (50% of marks)?

98% of candidates passed this question.

Many candidates scored very highly on this core topic. It was expected information be included on pharmaceutics, cost, availability and compatibilities. Relevant pharmacokinetics (onset/offset, titratability) and pharmacodynamics (including relevant receptors, nuances of haemodynamic effects e.g. effect on diastolic pressure and regional perfusion) should have been detailed. Adverse effects and safety profile (e.g. use in pregnancy, therapeutic index) should also have been included.

Good answers were structured and highlighted differences with specific facts and data.

G7i / 17B15: List the properties of an ideal inotrope (50 marks). How does adrenaline compare to these ideal properties (50 marks)?

Ceutics

Ideal

Adrenaline

Non toxic

Y

Stable in solution

Y

No reconstitution before use

N – inotropy requires infusion / reconstitution

Stable in air & light

N

Long shelf life

Y

Compatible w all fluids/drugs

N

No additives

N

Cost effective

Y

Does not support bacterial growth

Y – contains sodium metabisulphite

Standard dose (no dose calculation required)

N – requires titration

Administration via peripheral cannula
Not recommended

PD

Ideal

Adrenaline

MoA known

Y

Works on one receptor

Alpha and beta agonist, depending on dose

Cardiovascular only

Multiple sites of action

+ve inotropy

Y

No effect on myocardial O2 consumption

N

Increases MAP

Y

Maintains DBP

Y

Non-arrythmogenic

N

Improves regional perfusion

Y

PK

Ideal

Adrenaline

Rapid onset / offset

Y

Completely metabolised, organ independent

N

Inactive metabolites

Y

No tolerance

N

No concentration monitoring requirement

Y

Adverse Effects

Ideal

Adrenaline

None

Many

Safe in pregnancy

Can cause fetal HR acceleration

Wide therapeutic index

Dose dependant PD profile